Literature DB >> 19344978

Tumor necrosis factor-alfa in nonhealing venous leg ulcers.

Carlos A Charles1, Paolo Romanelli, Zuleika Bonilla Martinez, Fangchao Ma, Brenda Roberts, Robert S Kirsner.   

Abstract

BACKGROUND: Venous leg ulcers are responsible for more than half of all lower extremity ulcerations, affecting more than one million Americans annually. Studies have demonstrated alterations in levels of proinflammatory cytokines in patients with chronic wounds, including tumor necrosis factor-alfa (TNFalpha), which may be implicated in wound chronicity.
OBJECTIVE: To test the hypothesis that recalcitrant venous leg ulcers have increased local tissue TNFalpha as compared to normal skin.
METHODS: Five patients with nonhealing healing chronic venous leg ulcers were recruited. Two 4-mm punch biopsy specimens were obtained: one from the wound margin and one from noninvolved, non-sun exposed normal skin on the flexor aspect of the forearm. Tissue samples were processed using fixed with formalin stained by immunohistochemistry for TNFalpha. Qualitative and quantitative comparisons were made for the presence of TNFalpha receptor in all tissue samples, specifically comparing the presence of TNFalpha in nonhealing venous leg ulcer samples versus normal skin.
RESULTS: The overall staining score for nonhealing venous leg ulcers was significantly higher compared to respective normal skin samples (P = .01). In addition, immunostaining for TNFalpha was significantly less in the two nonhealing venous leg ulcers that were present for the shortest duration compared to the other ulcers of longer duration (P = .048). LIMITATIONS: The small sample size may mitigate the clinical implications of findings.
CONCLUSIONS: Increased levels of TNFalpha in nonhealing venous leg ulcers, especially those of longer duration, implies that excessive inflammation may be causal in wound chronicity and suggests potential therapeutic alternatives.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344978     DOI: 10.1016/j.jaad.2008.09.012

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa.

Authors:  Anirban Banerjee; Sean McNish; Victoria K Shanmugam
Journal:  Immunol Invest       Date:  2016-11-07       Impact factor: 3.657

2.  Adalimumab treatment leads to reduction of tissue tumor necrosis factor-alpha correlated with venous leg ulcer improvement: a pilot study.

Authors:  Joshua D Fox; Katherine L Baquerizo-Nole; Brian R Keegan; Flor Macquhae; Julia Escandon; Aliette Espinosa; Carmen Perez; Paolo Romanelli; Robert S Kirsner
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

3.  A prospective pilot study of ultrasound therapy effectiveness in refractory venous leg ulcers.

Authors:  Julia Escandon; Alejandra C Vivas; Robert Perez; Robert Kirsner; Stephen Davis
Journal:  Int Wound J       Date:  2012-02-01       Impact factor: 3.315

4.  Deletion of a tumor necrosis superfamily gene in mice leads to impaired healing that mimics chronic wounds in humans.

Authors:  Melissa L Petreaca; Danh Do; Sandeep Dhall; Darcie McLelland; Avo Serafino; Julia Lyubovitsky; Neal Schiller; Manuela M Martins-Green
Journal:  Wound Repair Regen       Date:  2012 May-Jun       Impact factor: 3.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.